sars cov 2 s1 domain  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC sars cov 2 s1 domain
    Frequency of IgG <t>anti-SARS-CoV-2</t> concentration categories among vaccinated and unvaccinated participants, comparing the percentage of individuals in divisions based on IgG levels every 1000 BAU/ml
    Sars Cov 2 S1 Domain, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars cov 2 s1 domain/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    sars cov 2 s1 domain - by Bioz Stars, 2024-06
    86/100 stars

    Images

    1) Product Images from "COVID-19 vaccination in healthcare workers: Long-term benefits and protection"

    Article Title: COVID-19 vaccination in healthcare workers: Long-term benefits and protection

    Journal: Central-European Journal of Immunology

    doi: 10.5114/ceji.2023.134250

    Frequency of IgG anti-SARS-CoV-2 concentration categories among vaccinated and unvaccinated participants, comparing the percentage of individuals in divisions based on IgG levels every 1000 BAU/ml
    Figure Legend Snippet: Frequency of IgG anti-SARS-CoV-2 concentration categories among vaccinated and unvaccinated participants, comparing the percentage of individuals in divisions based on IgG levels every 1000 BAU/ml

    Techniques Used: Concentration Assay

    sars cov 2 s1 domain  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC sars cov 2 s1 domain
    Sars Cov 2 S1 Domain, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars cov 2 s1 domain/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    sars cov 2 s1 domain - by Bioz Stars, 2024-06
    86/100 stars

    Images

    sars cov 2 s1 domain  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC sars cov 2 s1 domain
    Sars Cov 2 S1 Domain, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars cov 2 s1 domain/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    sars cov 2 s1 domain - by Bioz Stars, 2024-06
    86/100 stars

    Images

    recombinant sars cov 2 s1 rbd domain  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC recombinant sars cov 2 s1 rbd domain
    Recombinant Sars Cov 2 S1 Rbd Domain, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant sars cov 2 s1 rbd domain/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    recombinant sars cov 2 s1 rbd domain - by Bioz Stars, 2024-06
    86/100 stars

    Images

    recombinant sars cov 2 s1 rbd domain  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC recombinant sars cov 2 s1 rbd domain
    Results of the PRNT 50 assay, performed on 83 patients, after healing from severe <t> SARS-CoV-2 </t> infection.
    Recombinant Sars Cov 2 S1 Rbd Domain, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant sars cov 2 s1 rbd domain/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    recombinant sars cov 2 s1 rbd domain - by Bioz Stars, 2024-06
    86/100 stars

    Images

    1) Product Images from "Correlation between In Vitro Neutralization Assay and Serological Tests for Protective Antibodies Detection"

    Article Title: Correlation between In Vitro Neutralization Assay and Serological Tests for Protective Antibodies Detection

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms23179566

    Results of the PRNT 50 assay, performed on 83 patients, after healing from severe  SARS-CoV-2  infection.
    Figure Legend Snippet: Results of the PRNT 50 assay, performed on 83 patients, after healing from severe SARS-CoV-2 infection.

    Techniques Used: Infection

    sars cov 2 s1 domain  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC sars cov 2 s1 domain
    Comparison of <t>anti-SARS-CoV-2</t> antibody levels by group without distinguishing among vaccines. Group 1 (dark blue box): 2 doses more than 6 months before measurement, low antibody level (<2500), regardless of the declaration of COVID-19 prior infection; group 2 (blue box): 2 doses more than 6 months before measurement, high antibody levels (>2500), no declaration of COVID-19 prior to infection; group 3 (light blue box): 3 doses, regardless of the declaration of COVID-19 prior to infection and antibody levels.
    Sars Cov 2 S1 Domain, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars cov 2 s1 domain/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    sars cov 2 s1 domain - by Bioz Stars, 2024-06
    86/100 stars

    Images

    1) Product Images from "The Dynamics of Changes in the Concentration of IgG against the S1 Subunit in Polish Healthcare Workers in the Period from 1 to 12 Months after Injection, Including Four COVID-19 Vaccines"

    Article Title: The Dynamics of Changes in the Concentration of IgG against the S1 Subunit in Polish Healthcare Workers in the Period from 1 to 12 Months after Injection, Including Four COVID-19 Vaccines

    Journal: Vaccines

    doi: 10.3390/vaccines10040506

    Comparison of anti-SARS-CoV-2 antibody levels by group without distinguishing among vaccines. Group 1 (dark blue box): 2 doses more than 6 months before measurement, low antibody level (<2500), regardless of the declaration of COVID-19 prior infection; group 2 (blue box): 2 doses more than 6 months before measurement, high antibody levels (>2500), no declaration of COVID-19 prior to infection; group 3 (light blue box): 3 doses, regardless of the declaration of COVID-19 prior to infection and antibody levels.
    Figure Legend Snippet: Comparison of anti-SARS-CoV-2 antibody levels by group without distinguishing among vaccines. Group 1 (dark blue box): 2 doses more than 6 months before measurement, low antibody level (<2500), regardless of the declaration of COVID-19 prior infection; group 2 (blue box): 2 doses more than 6 months before measurement, high antibody levels (>2500), no declaration of COVID-19 prior to infection; group 3 (light blue box): 3 doses, regardless of the declaration of COVID-19 prior to infection and antibody levels.

    Techniques Used: Infection

    Comparisons of antibody levels following full vaccination with BNT162b2, taking into account the time factor and the incidence of SARS-CoV-2 infection. The error bars for marginal means with 95% confidence intervals (bootstrapped) are presented in turn: ( A ) the time elapsed after the full BNT162b2 vaccination; ( B ) the prior COVID-19 infection grouped with different time intervals elapsed after full BNT162b2 vaccination.
    Figure Legend Snippet: Comparisons of antibody levels following full vaccination with BNT162b2, taking into account the time factor and the incidence of SARS-CoV-2 infection. The error bars for marginal means with 95% confidence intervals (bootstrapped) are presented in turn: ( A ) the time elapsed after the full BNT162b2 vaccination; ( B ) the prior COVID-19 infection grouped with different time intervals elapsed after full BNT162b2 vaccination.

    Techniques Used: Infection

    Comparison of antibody levels after full BNT162b2 vaccination by group according to the time factor and frequency of SARS-CoV-2 infection. Box and whisker plots are presented in turn: ( A ) the time elapsed after the full BNT162b2 vaccination; ( B ) evidence of SARS-CoV-2 infection before vaccination. Group 1 (dark blue box): 2 doses, more than 6 months before measurement, low antibody levels (<2500 BAU/mL), regardless of the declaration of prior COVID-19 infection. Group 2 (green box): 2 doses, more than 6 months before the measurement, high antibody levels (>2500 BAU/mL), no declaration of prior COVID-19 infection. Group 3 (yellow box): 3 doses, regardless of the declaration of prior COVID-19 infection and antibody level. Group 1 (purple box): a group of participants who did not meet the criteria for belonging to Groups 1, 2, or 3.
    Figure Legend Snippet: Comparison of antibody levels after full BNT162b2 vaccination by group according to the time factor and frequency of SARS-CoV-2 infection. Box and whisker plots are presented in turn: ( A ) the time elapsed after the full BNT162b2 vaccination; ( B ) evidence of SARS-CoV-2 infection before vaccination. Group 1 (dark blue box): 2 doses, more than 6 months before measurement, low antibody levels (<2500 BAU/mL), regardless of the declaration of prior COVID-19 infection. Group 2 (green box): 2 doses, more than 6 months before the measurement, high antibody levels (>2500 BAU/mL), no declaration of prior COVID-19 infection. Group 3 (yellow box): 3 doses, regardless of the declaration of prior COVID-19 infection and antibody level. Group 1 (purple box): a group of participants who did not meet the criteria for belonging to Groups 1, 2, or 3.

    Techniques Used: Infection, Whisker Assay

    Comparisons of antibody levels following full vaccination with mRNA-1273, taking into account the time factor and the incidence of SARS-CoV-2 infection. The error bars for marginal means with 95% confidence intervals (bootstrapped) are presented in turn: ( A ) the time elapsed after the full mRNA-1273 vaccination; ( B ) the prior COVID-19 infection group with different time intervals elapsed after full mRNA-1273 vaccination.
    Figure Legend Snippet: Comparisons of antibody levels following full vaccination with mRNA-1273, taking into account the time factor and the incidence of SARS-CoV-2 infection. The error bars for marginal means with 95% confidence intervals (bootstrapped) are presented in turn: ( A ) the time elapsed after the full mRNA-1273 vaccination; ( B ) the prior COVID-19 infection group with different time intervals elapsed after full mRNA-1273 vaccination.

    Techniques Used: Infection

    Comparisons of antibody levels following full vaccination with ChAdOx1 nCoV-2019, taking into account the time factor and the incidence of SARS-CoV-2 infection. The error bars for marginal means with 95% confidence intervals (bootstrapped) are presented in turn: ( A ) the time elapsed after the full ChAdOx1 nCoV-2019 vaccination; ( B ) prior COVID-19 infection grouped with different time intervals elapsed after full ChAdOx1 nCoV-2019 vaccination.
    Figure Legend Snippet: Comparisons of antibody levels following full vaccination with ChAdOx1 nCoV-2019, taking into account the time factor and the incidence of SARS-CoV-2 infection. The error bars for marginal means with 95% confidence intervals (bootstrapped) are presented in turn: ( A ) the time elapsed after the full ChAdOx1 nCoV-2019 vaccination; ( B ) prior COVID-19 infection grouped with different time intervals elapsed after full ChAdOx1 nCoV-2019 vaccination.

    Techniques Used: Infection

    Comparisons of antibody levels following full vaccination with JNJ-78436735, taking into account the time factor and the incidence of SARS-CoV-2 infection. The error bars for marginal means with 95% confidence intervals (bootstrapped) are presented in turn: ( A ) the time elapsed after the full JNJ-78436735 vaccination; ( B ) prior COVID-19 infection grouped with different time intervals elapsed after full JNJ-78436735 vaccination.
    Figure Legend Snippet: Comparisons of antibody levels following full vaccination with JNJ-78436735, taking into account the time factor and the incidence of SARS-CoV-2 infection. The error bars for marginal means with 95% confidence intervals (bootstrapped) are presented in turn: ( A ) the time elapsed after the full JNJ-78436735 vaccination; ( B ) prior COVID-19 infection grouped with different time intervals elapsed after full JNJ-78436735 vaccination.

    Techniques Used: Infection

    sars cov 2 s1 domain  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC sars cov 2 s1 domain
    Box and whisker plots for the IgG <t>anti-SARS-CoV-2</t> antibody titers for various measurements.
    Sars Cov 2 S1 Domain, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars cov 2 s1 domain/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    sars cov 2 s1 domain - by Bioz Stars, 2024-06
    86/100 stars

    Images

    1) Product Images from "Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines"

    Article Title: Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines

    Journal: Vaccines

    doi: 10.3390/vaccines10010099

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements.

    Techniques Used: Whisker Assay

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements grouped by prior COVID-19 infection.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements grouped by prior COVID-19 infection.

    Techniques Used: Whisker Assay, Infection

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements grouped by vaccine type.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements grouped by vaccine type.

    Techniques Used: Whisker Assay

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers depending on prior COVID-19 infection.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers depending on prior COVID-19 infection.

    Techniques Used: Whisker Assay, Infection

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various vaccine types.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various vaccine types.

    Techniques Used: Whisker Assay

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for prior COVID-19 infection grouped by vaccine type.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for prior COVID-19 infection grouped by vaccine type.

    Techniques Used: Whisker Assay, Infection

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for the vaccine type grouped by prior COVID-19 infection.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for the vaccine type grouped by prior COVID-19 infection.

    Techniques Used: Whisker Assay, Infection

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibodies in all three measurements for various vaccine types grouped by prior COVID-19 infection.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibodies in all three measurements for various vaccine types grouped by prior COVID-19 infection.

    Techniques Used: Whisker Assay, Infection

    Error bars for 10% trimmed means for IgG anti-SARS-CoV-2 antibody titers with 95% confidence intervals for prior COVID-19 infection.
    Figure Legend Snippet: Error bars for 10% trimmed means for IgG anti-SARS-CoV-2 antibody titers with 95% confidence intervals for prior COVID-19 infection.

    Techniques Used: Infection

    Error bars for 10% trimmed means for IgG anti-SARS-CoV-2 antibody titers with 95% confidence intervals for the vaccine type.
    Figure Legend Snippet: Error bars for 10% trimmed means for IgG anti-SARS-CoV-2 antibody titers with 95% confidence intervals for the vaccine type.

    Techniques Used:

    Error bars for 10% trimmed means for IgG anti-SARS-CoV-2 antibody titers with 95% confidence intervals for each measurement.
    Figure Legend Snippet: Error bars for 10% trimmed means for IgG anti-SARS-CoV-2 antibody titers with 95% confidence intervals for each measurement.

    Techniques Used:

    Error bars for 10% trimmed means for IgG anti-SARS-CoV-2 antibody titers with 95% confidence intervals for all three measurements grouped by prior COVID-19 infection.
    Figure Legend Snippet: Error bars for 10% trimmed means for IgG anti-SARS-CoV-2 antibody titers with 95% confidence intervals for all three measurements grouped by prior COVID-19 infection.

    Techniques Used: Infection

    Error bars for 10% trimmed means for IgG anti-SARS-CoV-2 antibody titers with 95%confidence intervals for all three measurements grouped by vaccine type.
    Figure Legend Snippet: Error bars for 10% trimmed means for IgG anti-SARS-CoV-2 antibody titers with 95%confidence intervals for all three measurements grouped by vaccine type.

    Techniques Used:

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements grouped by gender.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements grouped by gender.

    Techniques Used: Whisker Assay

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements grouped by age category.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements grouped by age category.

    Techniques Used: Whisker Assay

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements grouped by blood type.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers for various measurements grouped by blood type.

    Techniques Used: Whisker Assay

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers depending on gender.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers depending on gender.

    Techniques Used: Whisker Assay

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers depending on age category.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers depending on age category.

    Techniques Used: Whisker Assay

    Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers depending on blood type.
    Figure Legend Snippet: Box and whisker plots for the IgG anti-SARS-CoV-2 antibody titers depending on blood type.

    Techniques Used: Whisker Assay

    sars cov 2 s1 domain  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC sars cov 2 s1 domain
    Correlation between quantitative ELISA and microneutralization assay. Binding <t>anti‐SARS‐CoV‐2</t> S1 IgG was determined quantitatively using the QuantiVac ELISA and titers of neutralizing antibodies were determined using the CPE reduction NT assay ( n = 123). Neutralization titers correspond to reciprocal plasma dilutions protecting 50% of the wells at incubation with 100 TCID 50 of SARS‐CoV‐2. Samples with a cytopathic effect (CPE) equal or similar to the negative control are depicted on the y ‐axis. Dotted and dashed lines indicate borderline and positivity cut‐offs, respectively. r s , Spearman rank‐order correlation coefficient
    Sars Cov 2 S1 Domain, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars cov 2 s1 domain/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    sars cov 2 s1 domain - by Bioz Stars, 2024-06
    86/100 stars

    Images

    1) Product Images from "Correlation between a quantitative anti‐SARS‐CoV‐2 IgG ELISA and neutralization activity"

    Article Title: Correlation between a quantitative anti‐SARS‐CoV‐2 IgG ELISA and neutralization activity

    Journal: Journal of Medical Virology

    doi: 10.1002/jmv.27287

    Correlation between quantitative ELISA and microneutralization assay. Binding anti‐SARS‐CoV‐2 S1 IgG was determined quantitatively using the QuantiVac ELISA and titers of neutralizing antibodies were determined using the CPE reduction NT assay ( n = 123). Neutralization titers correspond to reciprocal plasma dilutions protecting 50% of the wells at incubation with 100 TCID 50 of SARS‐CoV‐2. Samples with a cytopathic effect (CPE) equal or similar to the negative control are depicted on the y ‐axis. Dotted and dashed lines indicate borderline and positivity cut‐offs, respectively. r s , Spearman rank‐order correlation coefficient
    Figure Legend Snippet: Correlation between quantitative ELISA and microneutralization assay. Binding anti‐SARS‐CoV‐2 S1 IgG was determined quantitatively using the QuantiVac ELISA and titers of neutralizing antibodies were determined using the CPE reduction NT assay ( n = 123). Neutralization titers correspond to reciprocal plasma dilutions protecting 50% of the wells at incubation with 100 TCID 50 of SARS‐CoV‐2. Samples with a cytopathic effect (CPE) equal or similar to the negative control are depicted on the y ‐axis. Dotted and dashed lines indicate borderline and positivity cut‐offs, respectively. r s , Spearman rank‐order correlation coefficient

    Techniques Used: Enzyme-linked Immunosorbent Assay, Microneutralization Assay, Binding Assay, Neutralization, Incubation, Negative Control

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    ATCC sars cov 2 s1 domain
    Frequency of IgG <t>anti-SARS-CoV-2</t> concentration categories among vaccinated and unvaccinated participants, comparing the percentage of individuals in divisions based on IgG levels every 1000 BAU/ml
    Sars Cov 2 S1 Domain, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars cov 2 s1 domain/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    sars cov 2 s1 domain - by Bioz Stars, 2024-06
    86/100 stars
      Buy from Supplier

    86
    ATCC recombinant sars cov 2 s1 rbd domain
    Frequency of IgG <t>anti-SARS-CoV-2</t> concentration categories among vaccinated and unvaccinated participants, comparing the percentage of individuals in divisions based on IgG levels every 1000 BAU/ml
    Recombinant Sars Cov 2 S1 Rbd Domain, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant sars cov 2 s1 rbd domain/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    recombinant sars cov 2 s1 rbd domain - by Bioz Stars, 2024-06
    86/100 stars
      Buy from Supplier

    Image Search Results


    Frequency of IgG anti-SARS-CoV-2 concentration categories among vaccinated and unvaccinated participants, comparing the percentage of individuals in divisions based on IgG levels every 1000 BAU/ml

    Journal: Central-European Journal of Immunology

    Article Title: COVID-19 vaccination in healthcare workers: Long-term benefits and protection

    doi: 10.5114/ceji.2023.134250

    Figure Lengend Snippet: Frequency of IgG anti-SARS-CoV-2 concentration categories among vaccinated and unvaccinated participants, comparing the percentage of individuals in divisions based on IgG levels every 1000 BAU/ml

    Article Snippet: The tests were performed in 96-well microplates coated with the SARS-CoV-2 S1 domain (including RBD, receptor-binding domain) recombinantly expressed in the human cell line HEK293 (ATCC).

    Techniques: Concentration Assay